Folgen
Karin Berger
Karin Berger
Senior Scientist, Ludwig-Maximilian-University Hospital Munich
Bestätigte E-Mail-Adresse bei med.uni-muenchen.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Prevalence and incidence of Parkinson's disease in Europe
S Von Campenhausen, B Bornschein, R Wick, K Bötzel, C Sampaio, ...
European neuropsychopharmacology 15 (4), 473-490, 2005
9732005
Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1‐yr retrospective study
B Schramm, B Ehlken, A Smala, K Quednau, K Berger, D Nowak
European Respiratory Journal 21 (1), 116-122, 2003
2052003
Cost of illness and its predictors for Parkinson’s disease in Germany
AE Spottke, M Reuter, O Machat, B Bornschein, S von Campenhausen, ...
Pharmacoeconomics 23, 817-836, 2005
1992005
The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers
A Ihbe-Heffinger, B Ehlken, R Bernard, K Berger, C Peschel, HG Eichler, ...
Annals of oncology 15 (3), 526-536, 2004
1812004
Health-related quality of life and healthcare utilisation in patients with Parkinson’s disease: impact of motor fluctuations and dyskinesias
RC Dodel, K Berger, WH Oertel
Pharmacoeconomics 19, 1013-1038, 2001
1552001
Untersuchung von Krankheitskosten bei Patienten mit Alzheimer-Erkrankung in Deutschland
JF Hallauer, M Schons, A Smala, K Berger
Gesundheitsökonomie und Qualitätsmanagement 5 (2), 73-9, 2000
1362000
Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study
M Reuther, EA Spottke, J Klotsche, O Riedel, H Peter, K Berger, O Athen, ...
Parkinsonism & related disorders 13 (2), 108-114, 2007
1352007
Costs of illness and care in Parkinson's disease: an evaluation in six countries
S von Campenhausen, Y Winter, AR e Silva, C Sampaio, E Ruzicka, ...
European Neuropsychopharmacology 21 (2), 180-191, 2011
1332011
Clinical outcomes and resource utilization associated with haemophilia care in Europe
W Schramm, S Royal, B Kroner, E Berntorp, P Giangrande, C Ludlam, ...
Haemophilia 8 (1), 33-43, 2002
1332002
Cost‐of‐illness in patients with moderate and severe chronic psoriasis vulgaris in Germany: Krankheitskosten bei Patienten mit mittelschwerer und schwerer chronischer Psoriasis …
K Berger, B Ehlken, B Kugland, M Augustin
JDDG: Journal der Deutschen Dermatologischen Gesellschaft 3 (7), 511-518, 2005
1272005
The socioeconomic impact of narcolepsy
R Dodel, H Peter, T Walbert, A Spottke, C Noelker, K Berger, U Siebert, ...
Sleep 27 (6), 1123-1128, 2004
1212004
Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus
EA Spottke, J Volkmann, D Lorenz, P Krack, AM Smala, V Sturm, ...
Journal of neurology 249, 759-766, 2002
1022002
Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness
W Dietrich, K Thuermel, S Heyde, R Busley, K Berger
Journal of cardiothoracic and vascular anesthesia 19 (5), 589-596, 2005
782005
Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective
K Fischer, P Poonnoose, AL Dunn, P Babyn, MJ Manco‐Johnson, ...
Haemophilia 23 (1), 11-24, 2017
762017
Burden of oral mucositis: a systematic review and implications for future research
K Berger, D Schopohl, A Bollig, D Strobach, C Rieger, D Rublee, ...
Oncology research and treatment 41 (6), 399-405, 2018
752018
Epidemiology and health economics of COPD across Europe: a critical analysis
D Nowak, K Berger, B Lippert, K Kilgert, M Caeser, R Sandtmann
Treatments in respiratory medicine 4, 381-395, 2005
682005
The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches
TD Szucs, K Berger, DN Fisman, S Harbarth
BMC infectious diseases 1, 1-7, 2001
672001
Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX®) therapy in Germany
B Wefer, B Ehlken, J Bremer, H Burgdörfer, B Domurath, C Hampel, ...
World journal of urology 28, 385-390, 2010
662010
Cost effectiveness of haemophilia treatment: a cross-national assessment
B Lippert, K Berger, E Berntorp, P Giangrande, M van den Berg, ...
Blood coagulation & fibrinolysis 16 (7), 477-485, 2005
662005
Haemophilia care in Europe: the ESCHQoL study
W Schramm, A Gringeri, R Ljung, K Berger, A Crispin, M Bullinger, ...
Haemophilia 18 (5), 729-737, 2012
632012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20